SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSE (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
IfrsStatementLineItems [Line Items] | |||
Share based compensation | $ 3,657 | $ 3,269 | $ 306 |
Total | 3,059 | 2,711 | 1,898 |
Research and development expenses [member] | |||
IfrsStatementLineItems [Line Items] | |||
Salaries and related expenses | 2,796 | 2,228 | 2,166 |
Materials and laboratory expenses | 434 | 223 | 316 |
Share based compensation | 403 | 447 | 127 |
Travel expenses | 260 | 87 | 50 |
Depreciation and amortization | 172 | 197 | 255 |
Subcontractors and consultants | 135 | 344 | 374 |
Freight | 8 | 33 | 30 |
Other | 5 | 10 | 6 |
Reimbursement from paid pilots and proof of concept projects | (1,154) | (858) | (1,426) |
Total | $ 3,059 | $ 2,711 | $ 1,898 |
X | ||||||||||
- Definition Freight expense. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Reimbursement from paid pilots and proof of concept projects. No definition available.
|
X | ||||||||||
- Definition Research expense. No definition available.
|
X | ||||||||||
- Definition Subcontractors and consultants. No definition available.
|
X | ||||||||||
- Definition Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The expense of all forms of consideration given by an entity in exchange for a service rendered by employees or for the termination of employment. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'nature of expense' form for its analysis of expenses. [Refer: Expenses, by nature] Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The amount of expenditure directly attributable to research or development activities, recognised in profit or loss. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of expense arising from travel. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Details
|